• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.伊莱玛醌不可逆抑制结核分枝杆菌莽草酸激酶的机制。
Biochim Biophys Acta Proteins Proteom. 2018 May-Jun;1866(5-6):731-739. doi: 10.1016/j.bbapap.2018.04.007. Epub 2018 Apr 12.
2
Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.基于电喷雾-液相色谱-串联质谱的结核分枝杆菌莽草酸激酶活性和抑制的动力学评估分析方法的建立。
Anal Chem. 2015 Feb 17;87(4):2129-36. doi: 10.1021/ac503210n. Epub 2015 Jan 28.
3
Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.通过 LC-MS 从抗结核分枝杆菌化合物中鉴定出莽草酸激酶抑制剂。
Tuberculosis (Edinb). 2014 Mar;94(2):152-8. doi: 10.1016/j.tube.2013.12.004. Epub 2013 Dec 31.
4
The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.重组结核分枝杆菌莽草酸激酶作用模式:动力学和热力学分析。
PLoS One. 2013 May 6;8(5):e61918. doi: 10.1371/journal.pone.0061918. Print 2013.
5
Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.抗结核化合物文库筛选发现新型结核分枝杆菌莽草酸激酶抑制剂。
Appl Microbiol Biotechnol. 2016 Jun;100(12):5415-26. doi: 10.1007/s00253-015-7268-8. Epub 2016 Feb 18.
6
Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.结核分枝杆菌莽草酸激酶与莽草酸和一种ATP类似物复合物的晶体结构。
Biochemistry. 2006 Jul 18;45(28):8539-45. doi: 10.1021/bi0606290.
7
Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.基于结构的高通量虚拟筛选预测结核分枝杆菌莽草酸激酶抑制剂
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7. doi: 10.1016/j.bmcl.2008.05.003. Epub 2008 May 4.
8
Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.苯并噻唑衍生物作为新型结核分枝杆菌莽草酸激酶抑制剂:其变构抑制模式的鉴定与阐释
J Chem Inf Model. 2016 May 23;56(5):930-40. doi: 10.1021/acs.jcim.6b00056. Epub 2016 May 13.
9
Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.曼赞胺生物碱对结核分枝杆菌莽草酸激酶的慢结合抑制作用。
Biochemistry. 2018 Aug 14;57(32):4923-4933. doi: 10.1021/acs.biochem.8b00231. Epub 2018 Jul 31.
10
Shikimate kinase, a protein target for drug design.莽草酸激酶,一种药物设计的蛋白质靶点。
Curr Med Chem. 2014;21(5):592-604. doi: 10.2174/09298673113206660299.

引用本文的文献

1
Inhibition of Shikimate Kinase from Methicillin-Resistant by Benzimidazole Derivatives. Kinetic, Computational, Toxicological, and Biological Activity Studies.苯并咪唑衍生物对耐甲氧西林金黄色葡萄球菌的分支酸激酶的抑制作用:动力学、计算、毒理学和生物学活性研究。
Int J Mol Sci. 2024 May 7;25(10):5077. doi: 10.3390/ijms25105077.
2
Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.鉴定结核分枝杆菌莽草酸激酶的潜在抑制剂:分子对接、计算机毒性和体外实验。
J Comput Aided Mol Des. 2023 Mar;37(3):117-128. doi: 10.1007/s10822-022-00495-w. Epub 2022 Dec 22.
3
Advances in Key Drug Target Identification and New Drug Development for Tuberculosis.结核病关键药物靶标鉴定与新药研发进展。
Biomed Res Int. 2022 Feb 25;2022:5099312. doi: 10.1155/2022/5099312. eCollection 2022.
4
Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.伊立米酮通过降低丙酮酸脱氢酶激酶 1 的活性诱导癌细胞凋亡。
Int J Mol Sci. 2020 Aug 21;21(17):6021. doi: 10.3390/ijms21176021.
5
Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma Cells.伊利马醌诱导人口腔鳞状细胞癌细胞凋亡和自噬。
Biomedicines. 2020 Aug 20;8(9):296. doi: 10.3390/biomedicines8090296.

本文引用的文献

1
Tumor Protein (TP)-p53 Members as Regulators of Autophagy in Tumor Cells upon Marine Drug Exposure.肿瘤蛋白(TP)-p53家族成员作为海洋药物暴露后肿瘤细胞自噬的调节因子
Mar Drugs. 2016 Aug 16;14(8):154. doi: 10.3390/md14080154.
2
Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.基于电喷雾-液相色谱-串联质谱的结核分枝杆菌莽草酸激酶活性和抑制的动力学评估分析方法的建立。
Anal Chem. 2015 Feb 17;87(4):2129-36. doi: 10.1021/ac503210n. Epub 2015 Jan 28.
3
Activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells.用海海绵代谢产物异香豆素和乙基斯门醌激活p53可诱导结肠癌细胞凋亡和自噬。
Mar Drugs. 2015 Jan 16;13(1):543-57. doi: 10.3390/md13010543.
4
Ilimaquinone and ethylsmenoquinone, marine sponge metabolites, suppress the proliferation of multiple myeloma cells by down-regulating the level of β-catenin.伊立马醌和乙基司莫醌这两种海洋海绵代谢产物,通过下调β-连环蛋白水平来抑制多发性骨髓瘤细胞的增殖。
Mar Drugs. 2014 May 28;12(6):3231-44. doi: 10.3390/md12063231.
5
Inducers of hypoxic response: marine sesquiterpene quinones activate HIF-1.缺氧诱导因子 1 的激活剂:海洋倍半萜二氢醌
J Nat Prod. 2013 Jun 28;76(6):1175-81. doi: 10.1021/np400320r. Epub 2013 Jun 3.
6
Stimulation of KatG catalase activity by peroxidatic electron donors.过氧化物酶电子供体对 KatG 过氧化氢酶活性的刺激作用。
Arch Biochem Biophys. 2012 Sep 15;525(2):215-22. doi: 10.1016/j.abb.2012.06.003. Epub 2012 Jun 15.
7
Irreversible protein kinase inhibitors.不可逆蛋白激酶抑制剂。
Curr Med Chem. 2011;18(20):2981-94. doi: 10.2174/092986711796391705.
8
The resurgence of covalent drugs.共价药物的复兴。
Nat Rev Drug Discov. 2011 Apr;10(4):307-17. doi: 10.1038/nrd3410.
9
Synthesis and antitumor activity of diterpenylhydroquinone derivatives of natural ent-labdanes.天然 ent-劳丹烷二萜基对苯二酚衍生物的合成及抗肿瘤活性。
Molecules. 2010 Sep 17;15(9):6502-11. doi: 10.3390/molecules15096502.
10
Privileged scaffolds for library design and drug discovery.优先支架用于文库设计和药物发现。
Curr Opin Chem Biol. 2010 Jun;14(3):347-61. doi: 10.1016/j.cbpa.2010.02.018. Epub 2010 Mar 18.

伊莱玛醌不可逆抑制结核分枝杆菌莽草酸激酶的机制。

Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.

机构信息

Department of Drug Discovery and Development, Harrison School of Pharmacy, 3306 Walker Building, Auburn University, Auburn, AL 36849, USA.

Department of Chemistry and Biochemistry, 179 Chemistry Building, Auburn University, Auburn, AL 36849, USA.

出版信息

Biochim Biophys Acta Proteins Proteom. 2018 May-Jun;1866(5-6):731-739. doi: 10.1016/j.bbapap.2018.04.007. Epub 2018 Apr 12.

DOI:10.1016/j.bbapap.2018.04.007
PMID:29654976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11215815/
Abstract

Ilimaquinone (IQ), a marine sponge metabolite, has been considered as a potential therapeutic agent for various diseases due to its broad range of biological activities. We show that IQ irreversibly inactivates Mycobacterium tuberculosis shikimate kinase (MtSK) through covalent modification of the protein. Inactivation occurred with an apparent second-order rate constant of about 60 M s. Following reaction with IQ, LC-MS analyses of intact MtSK revealed covalent modification of MtSK by IQ, with the concomitant loss of a methoxy group, suggesting a Michael-addition mechanism. Evaluation of tryptic fragments of IQ-derivatized MtSK by MS/MS demonstrated that Ser and Thr residues were most frequently modified with lesser involvement of Lys and Tyr. In or near the MtSK active site, three residues of the P-loop (K15, S16, and T17) as well as S77, T111, and S44 showed evidence of IQ-dependent derivatization. Accordingly, inclusion of ATP in IQ reactions with MtSK partially protected the enzyme from inactivation and limited IQ-based derivatization of K15 and S16. Additionally, molecular docking models for MtSK-IQ were generated for IQ-derivatized S77 and T111. In the latter, ATP was observed to sterically clash with the IQ moiety. Out of three other enzymes evaluated, lactate dehydrogenase was derivatized and inactivated by IQ, but pyruvate kinase and catalase-peroxidase (KatG) were unaffected. Together, these data suggest that IQ is promiscuous (though not entirely indiscriminant) in its reactivity. As such, the potential of IQ as a lead in the development of antitubercular agents directed against MtSK or other targets is questionable.

摘要

异绵马醌(IQ)是一种海洋海绵代谢物,由于其广泛的生物活性,已被认为是治疗各种疾病的潜在治疗剂。我们表明,IQ 通过蛋白质的共价修饰不可逆地使结核分枝杆菌莽草酸激酶(MtSK)失活。失活反应的表观二级速率常数约为 60 M s。与 IQ 反应后,通过 LC-MS 分析完整的 MtSK 发现 IQ 共价修饰 MtSK,同时失去一个甲氧基,表明存在迈克尔加成机制。通过 MS/MS 对 IQ 衍生的 MtSK 肽段进行评估,表明 Ser 和 Thr 残基最常被修饰,而 Lys 和 Tyr 残基的参与程度较小。在 MtSK 的活性位点内或附近,P 环的三个残基(K15、S16 和 T17)以及 S77、T111 和 S44 显示出依赖于 IQ 的衍生化的证据。因此,在含有 MtSK 的 IQ 反应中加入 ATP 可部分保护酶免受失活,并限制 IQ 衍生化 K15 和 S16。此外,还生成了用于 MtSK-IQ 的分子对接模型,用于 IQ 衍生化的 S77 和 T111。在后一种情况下,观察到 ATP 与 IQ 部分发生空间冲突。在所评估的其他三种酶中,IQ 衍生化和失活了乳酸脱氢酶,但丙酮酸激酶和过氧化氢酶过氧化物酶(KatG)不受影响。综上所述,这些数据表明 IQ 在反应性方面是混杂的(尽管并非完全无差别)。因此,IQ 作为针对 MtSK 或其他靶标开发抗结核药物的先导化合物的潜力是值得怀疑的。